Clinically intelligent diagnostic devices and methods
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
C12Q-001/68
C12Q-001/70
G01N-033/53
출원번호
US-0996056
(2001-11-27)
발명자
/ 주소
Jacobs, Alice A.
Gupta, Vineet
Nikolic, Boris
출원인 / 주소
Intelligent Medical Devices, Inc.
대리인 / 주소
Fish &
인용정보
피인용 횟수 :
82인용 특허 :
34
초록▼
The invention relates to the clinically intelligent design of diagnostic devices (such as microarrays) and methods of making and using such devices in differential diagnoses of specific clinical symptoms or sets of symptoms. In one aspect, the devices include various probes used to perform parallel
The invention relates to the clinically intelligent design of diagnostic devices (such as microarrays) and methods of making and using such devices in differential diagnoses of specific clinical symptoms or sets of symptoms. In one aspect, the devices include various probes used to perform parallel screening of a number of analytes. The probes are clustered on the devices based on known clinical presentations of symptoms associated with specific diseases and disorders.
대표청구항▼
1. A method of determining a cause of one or more medical symptoms exhibited by a subject, the method comprising:(a) obtaining one or more biological samples from the subject; (b) obtaining an array of different probes or different sets of probes, wherein each probe or set of probes selectively inte
1. A method of determining a cause of one or more medical symptoms exhibited by a subject, the method comprising:(a) obtaining one or more biological samples from the subject; (b) obtaining an array of different probes or different sets of probes, wherein each probe or set of probes selectively interacts with a target associated with a different known cause of the one or more medical symptoms, and wherein the array includes at least (i) a first probe or set of first probes directed to a first target, wherein the first target comprises one or more markers for one or more infectious agents known to cause the one or more medical symptoms; and (ii) a second probe or set of second probes directed to a second target, wherein the second target comprises one or more genetic markers of the subject or one or more biological or chemical molecules, all known to be a cause of the one or more medical symptoms; (c) applying the one or more biological samples to the probes in the array under conditions that enable all of the probes to selectively interact with any targets in the biological sample; (d) detecting interactions; and (e) analyzing interactions to determine a cause of the one or more medical symptoms. 2. The method of claim 1, wherein the array of probes or sets of probes is arranged on a planar substrate.3. The method of claim 1, wherein each target is a nucleic acid, peptide, polypeptide, protein, antibody, antigen, small organic molecule, inorganic molecule, enzyme, or polysaccharide.4. The method of claim 1, wherein the array of probes comprises nucleic acid probes and polypeptide probes.5. The method of claim 1, wherein all of the probes in the array are polypeptides.6. The method of claim 5, wherein the probes are antibodies, antigens, enzymes, zinc-finger binding proteins, minor-groove binders, transcriptional factors, combinations thereof, or chimeras thereof.7. The method of claim 1, wherein the subject is a plant or animal.8. The method of claim 1, wherein the subject is a human.9. The method of claim 1, wherein the subject is deceased.10. The method of claim 1, wherein the array includes four or more different probes or sets of probes, wherein each probe or set of probes is directed to a different target, and wherein the different first and second targets comprise at least a marker for a virus, a marker for a bacteria, a biological molecule, and a genetic marker of the subject.11. The method of claim 1, wherein the biological sample is a blood, cerebrospinal fluid, cell culture, urine, sweat, buccal swab, tissue biopsy, or aspiration sample.12. The method of claim 2, wherein the probes are attached to the substrate using covalent or non-covalent bonds.13. The method of claim 2, wherein the probes are attached to the substrate using amide or thiol bonds.14. The method of claim 1, wherein the probes are expressed on the surface of genetically modified cells.15. The method of claim 1, wherein a probe selectively interacts with a target by specifically binding to the target to form a complex.16. The method of claim 1, wherein a first probe selectively interacts with a target associated with an infectious disease caused by a bacteria, virus, or fungus, and a second, different probe selectively interacts with a target associated with a genetic cause.17. The method of claim 1, wherein the array of probes further comprises probes that assay for the absence of a causative agent of one or more medical symptoms.18. A method of claim 1, wherein all of the probes selectively interact with their respective targets under the same conditions.19. The method of claim 1, wherein the array of probes comprises nucleic acid probes.20. The method of claim 1, wherein all of the probes in the array are nucleic acid probes.21. The method of claim 1, wherein the array further comprises a third probe or set of third probes directed to a third target, wherein the third target comprises a marker for a therapeutic optimization factor of the subject, a marker for a therapeutic optimization factor of the first target, or both.22. The method of claim 1, wherein the biological or chemical molecule is a cancer marker, vascular marker, inflammatory marker, endocrine marker, metabolic marker, or autoimmune marker.23. The method of claim 1, wherein the biological or chemical molecule is an immunoglobulin, self-antigen, or antigen.24. The method of claim 1, wherein the biological or chemical molecule is a poison, drug, or a small organic or inorganic molecule.25. The method of claim 1, wherein the infectious agent is a virus, bacteria, fungus, or pathogenic plant.26. The method of claim 1, further comprising determining the susceptibility of the subject to a cause of the one or more medical symptoms; wherein the array further includes a third probe or set of third probes directed to a third target, wherein the third target comprises one or more genetic markers or proteins associated with the susceptibility of the subject to a cause of the one or more medical symptoms; and wherein analyzing further comprises analyzing interactions to determine the susceptibility of the subject to a cause of the one or more medical symptoms.27. The method of claim 1, further comprising assessing the suitability of one or more therapeutic agents to treat the cause of the one or more medical symptoms; wherein the array further includes a third probe or set of third probes directed to a third target, wherein the third target comprises one or more markers for one or more therapeutic optimization factors; and wherein analyzing further comprises analyzing interactions to determine the suitability of a therapeutic agent to treat a cause of the one or more symptoms.28. The method of claim 27, wherein the third target comprises one or more markers for one or more therapeutic optimization factors for (i) two or more of the first target, (ii) two or more of the second target, or (iii) one or more of each of the first and second targets.29. The method of claim 26, further comprising assessing the suitability of one or more therapeutic agents to treat the cause of the one or more medical symptoms; wherein the array further includes a fourth probe or set of fourth probes directed to a fourth target, wherein the fourth target comprises one or more markers for one or more therapeutic optimization factors; and wherein analyzing further comprises analyzing interactions to determine the suitability of a therapeutic agent to treat a cause of the one or more symptoms.30. The method of claim 27, wherein the therapeutic optimization factor is tolerance, intolerance, or susceptibility of the subject or an infectious agent to a specific drug.31. The method of claim 27, wherein the marker for the therapeutic optimization factor is a gene in a pathogen that causes susceptibility, resistance, or an idiosyncratic reaction of the pathogen when exposed to a therapeutic agent.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (34)
Chang Tse W. (Houston TX), Antibody matrix device and method for evaluating immune status.
Fodor Stephen P. A. (Palo Alto CA) Pirrung Michael C. (Durham NC) Read J. Leighton (Palo Alto CA) Stryer Lubert (Stanford CA), Array of oligonucleotides on a solid substrate.
Palva Airi M. (Helsinki FIX) Ranki Tuula M. (Espoo FIX) Sderlund Hans E. (Espoo FIX), Arrays of alternating nucleic acid fragments for hybridization arrays.
Persing David H. (Rochester MN) Hunt John J. (Rochester MN) Young Karen K. Y. (San Ramon CA) Felmlee Teresa A. (Oronoco MN) Roberts Glenn D. (Rochester MN) Whelan A. Christian (Rochester MN), Detection of a genetic locus encoding resistance to rifampin in mycobacterial cultures and in clinical specimens.
Gordon Julian (Arlesheim CHX) Hawkes Richard (Allschwil IL CHX) Niday Evelyn (Arlington Heights IL) Towbin Harry (Allschwil CHX), Devices and kits for immunological analysis.
Hayes Donald J. (Plano TX) Wallace David B. (Dallas TX) Frederickson Christopher J. (Little Elm TX), Method and apparatus for making miniaturized diagnostic arrays.
Mirzabekov Andrei Darievich,RUX ; Proudnikov Dimitri Y.,RUX ; Timofeev Edward N.,RUX ; Kochetkova Svetlana V.,RUX ; Florentiev Vladimir L.,RUX ; Shick Valentine V.,RUX, Methods for immobilizing nucleic acids on a gel substrate.
Merkh Carl W. (Lindenhurst IL) Defreese James D. (Wildwood IL) Durley ; III ; deceased Benton A. (late of Antioch IL by Robert W. Durley ; executrix), Test array for performing assays.
Angell, Robert Lee; Friedlander, Robert R.; Kraemer, James R., Automatic generation of new rules for processing synthetic events using computer-based learning processes.
Friedlander, Robert R.; Hennessy, Richard A.; Kraemer, James R., Deriving a hierarchical event based database having action triggers based on inferred probabilities.
Friedlander, Robert R.; Kraemer, James R., Describing a paradigmatic member of a task directed community in a complex heterogeneous environment based on non-linear attributes.
Friedlander, Robert R.; Kraemer, James R., Describing a paradigmatic member of a task directed community in a complex heterogeneous environment based on non-linear attributes.
Erickson, Page A.; Everman, Michael R.; Bell, Michael S.; Edberg, Kevin S.; Botke, Matthew M., Enhanced fluidic method and apparatus for automated rapid immunohistochemistry.
Friedlander, Robert R.; Goldszmidt, German S.; Kraemer, James R.; Lougee, Robin; Osipov, Kirill M., Generating candidate inclusion/exclusion cohorts for a multiply constrained group.
Erickson, Page A.; Everman, Michael R.; Bell, Michael S.; Edberg, Kevin S.; Sawatzky, Brian D.; Botke, Matthew M., Method and apparatus for automated rapid immunohistochemistry.
Gómez-Elvira Rodríguez, Javier; Sebastián Martínez, Eduardo; Briones Llorente, Carlos; Parro García, Victor; Rodríguez Manfredi, José Antonio; Compostizo Sañudo, Carlos; Herrero Gonzalo, Pedro Luis; Pérez Mercader, Juan, Method and apparatus for detecting substances or analytes from the analysis of one or more samples.
Schwertner, Heiko; Runge, Dorothee Monika, Method and device for the determination of several analytes with simultaneous internal verification in a graphical combination.
Friedlander, Robert R.; Kraemer, James R., Optimizing federated and ETL'd databases with considerations of specialized data structures within an environment having multidimensional constraint.
Friedlander, Robert R.; Hennessy, Richard A.; Khan, Anwer Mujahid; Kraemer, James R., Optimizing the selection, verification, and deployment of expert resources in a time of chaos.
Erickson, Page A.; Everman, Michael R.; Bell, Michael S.; Edberg, Kevin S.; Botke, Matthew M., Parallel processing fluidic method and apparatus for automated rapid immunohistochemistry.
Brackett, Paul L.; Friedlander, Robert R.; Jackson, Anne O.; Kraemer, James R., Populating a task directed community in a complex heterogeneous environment based on non-linear attributes of a paradigmatic cohort member.
Friedlander, Robert R.; Kraemer, James R.; Lougee, Robin; Osipov, Kirill M., Probabilistic optimization of resource discovery, reservation and assignment.
Friedlander, Robert R.; Kraemer, James R.; Lougee-Heimer, Robin; Osipov, Kirill M., Probabilistic optimization of resource discovery, reservation and assignment.
Friedlander, Robert R.; Hennessy, Richard A.; Kraemer, James R., System and method for deriving a hierarchical event based database having action triggers based on inferred probabilities.
Friedlander, Robert R.; Hennessy, Richard A.; Kraemer, James R., System and method for deriving a hierarchical event based database optimized for analysis of biological systems.
Friedlander, Robert R.; Hennessy, Richard A.; Kraemer, James R., System and method for deriving a hierarchical event based database optimized for analysis of chaotic events.
Friedlander, Robert R.; Hennessy, Richard A.; Kraemer, James R., System and method for deriving a hierarchical event based database optimized for analysis of criminal and security information.
Friedlander, Robert R.; Hennessy, Richard A.; Kraemer, James R., System and method for deriving a hierarchical event based database optimized for clinical applications.
Friedlander, Robert R.; Hennessy, Richard A.; Kraemer, James R., System and method for deriving a hierarchical event based database optimized for pharmaceutical analysis.
Friedlander, Robert R.; Hennessy, Richard A.; Kraemer, James R., System and method for deriving a hierarchical event based database optimized for privacy and security filtering.
Friedlander, Robert R.; Khan, Anwer Mujahid; Kraemer, James R., System and method for managing a chaotic event by optimizing decision subdivisions subject to multidimensional constraints.
Friedlander, Robert R.; Kraemer, James R., System and method for managing a chaotic event by providing optimal and adaptive sequencing of decision sets with supporting data.
Friedlander, Robert R.; Kraemer, James R., System and method for optimal and adaptive process unification of decision support functions associated with managing a chaotic event.
Friedlander, Robert R.; Kraemer, James R., System and method for optimally customizable and adaptive personalized information display for information associated with managing a chaotic event.
Friedlander, Robert R.; Khan, Anwer Mujahid; Hennessy, Richard A.; Kraemer, James R., System and method for optimizing project subdivision using data and requirements focuses subject to multidimensional constraints.
Friedlander, Robert R.; Hennessy, Richard A.; Kraemer, James R., System and method of accident investigation for complex situations involving numerous known and unknown factors along with their probabilistic weightings.
Friedlander, Robert R.; Hennessy, Richard A.; Kraemer, James R.; Rollins, John Baxter, System and method to optimize control cohorts using clustering algorithms.
Wasson, James; Frankovich, John Kent; Holmes, Elizabeth A.; Smith, Timothy; Chen, Michael; Young, Daniel, Systems and methods for fluid and component handling.
Holmes, Elizabeth A.; Pangarkar, Chinmay; Anekal, Samartha; Frankovich, John K.; Chen, Michael; Smith, Timothy, Systems and methods for multi-analysis.
Gibbons, Ian; Nugent, Anthony J.; Delacruz, Anthony; Young, Daniel L.; Holmes, Elizabeth A.; Drake, Andrew; Kemp, Timothy Michael; Balwani, Sunny; Pangarkar, Chinmay, Systems and methods for sample use maximization.
Erickson, Page A.; Everman, Michael R.; Bell, Michael S.; Edberg, Kevin S.; Botke, Matthew M., Wicking cassette method and apparatus for automated rapid immunohistochemistry.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.